Page results
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Mepilex® dressing on their skin that has broken down due to your radiotherapy or proton beam therapy treatment.
